BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34238351)

  • 1. PIAS1 potentiates the anti-EBV activity of SAMHD1 through SUMOylation.
    Saiada F; Zhang K; Li R
    Cell Biosci; 2021 Jul; 11(1):127. PubMed ID: 34238351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication.
    Sugiokto FG; Saiada F; Zhang K; Li R
    mBio; 2024 Feb; 15(2):e0316823. PubMed ID: 38236021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication.
    Sugiokto FG; Saiada F; Zhang K; Li R
    bioRxiv; 2023 Aug; ():. PubMed ID: 37609256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved Herpesvirus Protein Kinases Target SAMHD1 to Facilitate Virus Replication.
    Zhang K; Lv DW; Li R
    Cell Rep; 2019 Jul; 28(2):449-459.e5. PubMed ID: 31291580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMOylation of SAMHD1 at Lysine 595 is required for HIV-1 restriction in non-cycling cells.
    Martinat C; Cormier A; Tobaly-Tapiero J; Palmic N; Casartelli N; Mahboubi B; Coggins SA; Buchrieser J; Persaud M; Diaz-Griffero F; Espert L; Bossis G; Lesage P; Schwartz O; Kim B; Margottin-Goguet F; Saïb A; Zamborlini A
    Nat Commun; 2021 Jul; 12(1):4582. PubMed ID: 34321470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.
    Brown JR; Conn KL; Wasson P; Charman M; Tong L; Grant K; McFarlane S; Boutell C
    J Virol; 2016 Jul; 90(13):5939-5952. PubMed ID: 27099310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genome-wide screen of Epstein-Barr virus proteins that modulate host SUMOylation identifies a SUMO E3 ligase conserved in herpesviruses.
    De La Cruz-Herrera CF; Shire K; Siddiqi UZ; Frappier L
    PLoS Pathog; 2018 Jul; 14(7):e1007176. PubMed ID: 29979787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
    González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
    Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cyclin-Binding Motif in Human SAMHD1 Is Required for Its HIV-1 Restriction, dNTPase Activity, Tetramer Formation, and Efficient Phosphorylation.
    St Gelais C; Kim SH; Maksimova VV; Buzovetsky O; Knecht KM; Shepard C; Kim B; Xiong Y; Wu L
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29321329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein inhibitor of activated STAT1 Ser
    Liu SY; Ma YL; Hsu WL; Chiou HY; Lee EHY
    Br J Pharmacol; 2019 Jun; 176(11):1793-1810. PubMed ID: 30849179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.
    Hagemeier SR; Dickerson SJ; Meng Q; Yu X; Mertz JE; Kenney SC
    J Virol; 2010 May; 84(9):4383-94. PubMed ID: 20181712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
    Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
    Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-translational modification of Rta of Epstein-Barr virus by SUMO-1.
    Chang LK; Lee YH; Cheng TS; Hong YR; Lu PJ; Wang JJ; Wang WH; Kuo CW; Li SS; Liu ST
    J Biol Chem; 2004 Sep; 279(37):38803-12. PubMed ID: 15229220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIAS1-mediated SUMOylation of influenza A virus PB2 restricts viral replication and virulence.
    Wang G; Zhao Y; Zhou Y; Jiang L; Liang L; Kong F; Yan Y; Wang X; Wang Y; Wen X; Zeng X; Tian G; Deng G; Shi J; Liu L; Chen H; Li C
    PLoS Pathog; 2022 Apr; 18(4):e1010446. PubMed ID: 35377920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B Cell Receptor Activation and Chemical Induction Trigger Caspase-Mediated Cleavage of PIAS1 to Facilitate Epstein-Barr Virus Reactivation.
    Zhang K; Lv DW; Li R
    Cell Rep; 2017 Dec; 21(12):3445-3457. PubMed ID: 29262325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAMHD1 acetylation enhances its deoxynucleotide triphosphohydrolase activity and promotes cancer cell proliferation.
    Lee EJ; Seo JH; Park JH; Vo TTL; An S; Bae SJ; Le H; Lee HS; Wee HJ; Lee D; Chung YH; Kim JA; Jang MK; Ryu SH; Yu E; Jang SH; Park ZY; Kim KW
    Oncotarget; 2017 Sep; 8(40):68517-68529. PubMed ID: 28978134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
    Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein inhibitor of activated STAT1 (PIAS1) inhibits IRF8 activation of Epstein-Barr virus lytic gene expression.
    Zhang K; Lv DW; Li R
    Virology; 2020 Jan; 540():75-87. PubMed ID: 31743858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein inhibitor of activated STAT 1 (PIAS1) is identified as the SUMO E3 ligase of CCAAT/enhancer-binding protein β (C/EBPβ) during adipogenesis.
    Liu Y; Zhang YD; Guo L; Huang HY; Zhu H; Huang JX; Liu Y; Zhou SR; Dang YJ; Li X; Tang QQ
    Mol Cell Biol; 2013 Nov; 33(22):4606-17. PubMed ID: 24061474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin Modification of the Epstein-Barr Virus Immediate Early Transactivator Zta.
    Zhao M; Nanbo A; Becnel D; Qin Z; Morris GF; Li L; Lin Z
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.